SCHEMBL6760480

SCHEMBL6760480

CC(C)C(N)(CC(c1ccccc1)c1cc(CO)ccc1OC(=O)c1ccccc1)C(C)C

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM2 P08172 1/20 0.51
CHRM1 P11229 1/20 0.51
KMT2A Q03164 4/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
CYP4F2 P78329 1/20 0.36
CYP4A11 Q02928 1/20 0.36
ELANE P08246 3/20 0.35
MAPT P10636 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
SLC6A3 Q01959 1/20 0.34
HPGD P15428 1/20 0.34
HPGDS O60760 1/20 0.33
NPC1 O15118 1/20 0.33
TP53 P04637 1/20 0.33
XBP1 P17861 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6761854 0.89 CHRM2 (0.42) CHRM2CHRM1KMT2AMEN1CYP3A4
SCHEMBL9220687 0.82 CHRM2 (0.43) CHRM2CHRM1MAPTSMN1; SMN2HPGD
SCHEMBL1354181 0.79 LMNA (0.40) CHRM2CHRM1KMT2ACYP3A4TDP1
SCHEMBL6757054 0.79 CHRM2 (0.52) CHRM2CHRM1KMT2AMEN1CYP3A4
SCHEMBL2167951 0.78 CHRM2 (0.80) CHRM2CHRM1KMT2AMEN1CYP3A4
SCHEMBL2168552 0.78 CHRM2 (0.80) CHRM2CHRM1KMT2AMEN1CYP3A4
SCHEMBL27491765 0.78 CHRM2 (0.70) CHRM2CHRM1KMT2AMEN1CYP3A4
SCHEMBL6760711 0.78 CHRM2 (0.42) CHRM2CHRM1KMT2AELANENPC1
SCHEMBL27507223 0.78 CHRM2 (0.70) CHRM2CHRM1KMT2AMEN1CYP3A4
SCHEMBL3779737 0.77 ELANE (0.44) CHRM2CHRM1CYP3A4ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8338478-B2 Derivatives of 3,3-diphenylpropylamines UCB PHARMA GMBH (DE) 2012-12-25 US disclosed
US-20040186061-A1 Novel derivatives of 3,3-diphenylpropylamines SCHWARZ PHARMA AG 2004-09-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040186061-A1 Novel derivatives of 3,3-diphenylpropylamines ADRB3, ADRA1D, TNNC1 CHRM2 136/4885CHRM1 227/4885KMT2A 3711/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.